STOCKHOLM, March 9, 2017 /PRNewswire/ -- As SCA communicated in December 2016, the Group hasentered into an agreement to acquire BSN medical, a leading medical solutions company. Closing is expected to take place during the second quarter 2017. BSN medical's sales for 2016 amounted to EUR 850m (SEK
1)Excluding items affecting comparability
NB: This information is information that SCA is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 20:00 CET on March 9, 2017.
Karl Stoltz, Media Relations Manager, +46-8-788-51-55
For additional information please contact:Johan Karlsson, Vice President Investor Relations, 46 (0)8 788 51 30Karl Stoltz, Media Relations Manager, 46 (0)8 788 51 55
This information was brought to you by Cision http://news.cision.comhttp://news.cision.com/sca/r/bsn-medical-s-sales-and-ebitda-for-2016,c2209205
The following files are available for download:
http://mb.cision.com/Main/600/2209205/640475.pdf BSN medicalâs sales and EBITDA for 2016
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bsn-medicals-sales-and-ebitda-for-2016-300421406.html
Subscribe to our Free Newsletters!
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...View All